Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT

Launched by YU SHI · Jul 18, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to understand how different characteristics of the pancreas can be seen using a special type of CT scan called spectral CT. The researchers want to see how the pancreas functions in both healthy and diseased states by analyzing the data collected from patients who have undergone CT scans at the hospital. By comparing this new information with traditional CT scans, the study aims to find patterns that could help in diagnosing pancreatic conditions more accurately.

To be eligible for this trial, you should be a patient who has visited the hospital for various reasons since March 2024 and has received a pancreatic CT scan using spectral technology. However, if you’ve had prior pancreatic surgery that left incomplete tissue or have serious health issues that affect organ function, you wouldn’t be able to participate. If you join the study, you can expect to contribute to valuable research that may improve how pancreatic diseases are diagnosed and understood in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1.Since March 2024, I have been visiting our hospital for various reasons and have undergone CT scans involving the pancreas (using energy spectrum CT)
• Exclusion Criteria:
• • 1. Previous pancreatic surgery with incomplete pancreatic tissue.
• • 2. Severe systemic diseases that result in severe organ dysfunction
• • 3. Excessive pancreatic atrophy or other reasons cannot accurately delineate ROI